R E S E A R C H How citation distortions create unfounded authority : analysis of a citation network Steven A Greenberg , associate professor of neurology ABSTRACT Objective To understand belief in a specific scientific claim by studying the pattern of citations among papers stating it . Design A complete citation network was constructed from all PubMed indexed English literature papers addressing the belief that β amyloid , a protein accumulated in the brain in Alzheimer ’ s disease , is produced by and injures skeletal muscle of patients with inclusion body myositis . Social network theory and graph theory were used to analyse this network . Main outcome measures Citation bias , amplification , and invention , and their effects on determining authority . Results The network contained 242 papers and 675 citations addressing the belief , with 220553 citation pathssupportingit . Unfoundedauthoritywasestablished by citation bias against papers that refuted or weakened the belief ; amplification , the marked expansion of the belief system by papers presenting no data addressing it ; and forms of invention such as the conversion of hypothesis into fact through citation alone . Extension of thisnetworkintotextwithingrantsfundedbytheNational Institutes of Health and obtained through the Freedom of Information Act showed the same phenomena present and sometimes used to justify requests for funding . Conclusion Citation is both an impartial scholarly method and a powerful form of social communication . Through distortions in its social use that include bias , amplification , and invention , citation can be used to generate information cascades resulting in unfounded authority of claims . Construction and analysis of a claim specific citation network may clarify the nature of a published belief system and exposedistorted methods of social citation . INTRODUCTION Biomedical knowledge arises from scientific data . The means by which this occurs within individual scientific papers is a generally accepted process whereby papers report rationale , methods , results , and conclusions . How an entire belief system shared by a scientific com - munity ultimately evolves from data across all papers withinaspecialtyislesswellunderstood . Idescribeand apply methods for the analysis of such belief systems using a specific example . Thebeliefsystemstudiedisthataprotein , β amyloid , known for its role in injuring brain in Alzheimer ’ s dis - ease , is also produced by and injures skeletal muscle fibres in the muscle disease sporadic inclusion body myositis . This belief system was chosen for analysis because of its importance to the care of patients with inclusion body myositis , as this view seems to be accepted by many as likely or established fact ( at least 200 different journal articles have stated such ) , with β amyloid production often reported to be a central ele - ment in the pathogenesis of the disease ( see web extra note 1 ) , and directs research and treatment trials in the specialty . The approach taken here was simply to col - lectallstatementsinthemedicalliteratureonthisbelief system and to study the pattern of citation among them — that is , how each statement is supported by reference to other papers . METHODS The methods are fully described in web extra note 2 . Briefly , queries identified all English language PubMed indexed articles potentially containing state - ments pertaining to any of three related molecules ( β amyloid precursor protein , its transcript , or one of its potential cleaved protein products , β amyloid ) and muscle disease . These 766 papers ( see web extra table 1 ) were searched for statements addressing the belief that these molecules are abnormally and specifi - cally present in muscle fibres of patients with inclusion body myositis among many other muscle diseases , identifying 302 papers 1 - 302 addressing the broad cate - gory of “ amyloid ” and inclusion body myositis of which 242 papers discussed these specific molecules ( see web extra table 2 ) . I collected all statements addressing the belief and citations supporting these statements . Each paper was classified as primary data ( containing experimental data addressing the specific and abnormal presence of these molecules in inclusion body myositis muscle ) , myositis review ( review papers with the term myositis or the equivalent in their title ) , model ( reporting cell culture or animal model experi - ments ) , or other ( all other papers ) . I classified each cita - tion as supportive , neutral , or critical according to how its underlying statement supported the belief . A net - work was then constructed representing papers as nodes and citations as links from one node to another . Children ’ s Hospital Informatics Program and Department of Neurology , Brigham and Women ’ s Hospital , Harvard Medical School , 75 Francis Street , Boston , MA 02115 , USA Correspondence to : S A Greenberg sagreenberg @ partners . org Cite this as : BMJ2009 ; 339 : b2680 doi : 10 . 1136 / bmj . b2680 BMJ | ONLINE FIRST | bmj . com page 1 of 14 Another investigator ( Anthony Amato ) validated text and citation extraction for 17 % of the papers , including all primary data papers . This citation network was further extended into research proposals funded by the US National Insti - tutes of Health , obtained through the Freedom of Information Act in accordance with National Institutes of Health policy . This claim specific citation network was then ana - lysed using graph theory 303 ( see methods in web extra ) . Briefly , custom MATLAB software ( Math - Works ; Natick , MA ) and the MatlabBGL package ( written by David Gleich ) were used for the analysis of adjacency matrices representing these networks . A centrality measure 304 on the papers was defined ( called the citation path index ; similar to other variants of cen - trality measure 305 ) . Authority was measured according to the method of Kleinberg . 306 Visualisation of net - works was carried out using Pajek ( http : / / vlado . fmf . uni - lj . si / pub / networks / pajek / ) . The maximum likeli - hood estimate method 307 was implemented in MATLAB , with code available from www . santafe . edu / aaronc / powerlaws / . RESULTS Authority and belief in a claim specific citation network The claim that β amyloid and its precursors are abnor - mally and specifically present in inclusion body myo - sitis muscle fibres among many other muscle diseases was studied . The 242 papers containing statements addressing it ( all exact text provided in web extra table 3 ) and the 675 citations ( not counting duplicates from one paper to another ; see web extra table 4 ) sup - porting these statements were used to construct a claim specific citation network ( fig 1 ) . This network con - tained 220609 citation paths , with chains of citations flowing from one paper to the next representing the entire National Library of Medicine PubMed indexed discourse on the claim as of 26 October 2007 . The his - torical growth and various mathematical properties 308 of this network are discussed in web extra note 3 . Within networkscertainnodes may be recognisedas “ authorities , ” 306 receiving large amounts of network traffic . Such authorities can be identified by computa - tional methods alone through examining the patterns of connections among the nodes ; this is how many internet search engines identify authoritative web pages . Because citation is in part an act of communica - tion within a community of people , social network theory 309 in particular can be used to analyse it . Under social network theory , authority of a claim indi - cates the community ’ s net belief about it . Using these computational methods , 306 four primary data papers , five model papers , and one review paper constituted the 10 most authoritative papers . All these papers expressed the view that the claim was true . Citation bias against critical primary data Of the 10 most authoritative papers , four provided experimental data addressing the claim , reporting the presence of these molecules in inclusion body myositis muscle fibres . 74757980 All four papers were from the same laboratory , two of which 7980 probably reported mostly the same data without citing each other , a Year Papers Citations 2007 = Primary data = Supportive = Neutral = Critical = Diversion = Myositis review = Animal / cell culture model = Other = Other data = Authority 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 Critical Supportive Primary data Models Other / other data Myositis reviews Fig 1 | Claim specific citation network . Citations regarding claim that β amyloid precursor protein mRNA or protein , or β amyloid protein , is abnormally present in inclusion body myositis muscle . The network is organised according to paper category and year of publication . Authority status ( yellow ) was defined computationally by network theory . Many citations flow to supportive primary data but not critical data . Papers are represented as nodes ( n = 218 ) and citations as directed edges ( supportive n = 636 , neutral n = 18 , critical n = 21 , diversion n = 3 ) . Twenty four papers contain statements pertaining to claim but do not make or receive citations about it ( not shown ) . RESEARCH page 2 of 14 BMJ | ONLINE FIRST | bmj . com practice currently viewed as one that distorts available evidence ( see web extra note 4 ) . Major technical weak - nesses were present in these papers , most notably a lack of quantitative data as to how many affected mus - cle fibres were seen and a lack of specificity of reagents for distinguishing β amyloid protein from β amyloid precursor protein ( see web extra note 5 ) . Inspection of the network disclosed six primary data papersthatwererelativelyisolated , receivingno orfew citations ( fig 1 ) . These papers contained data that refuted or weakened the claim . Three papers 717377 from independent laboratories reported that in a com - bined 35 patients with inclusion body myositis studied , 28 had no affected muscle fibres while the remaining seven had five or fewer affected muscle fibres ( typical biopsy sections contain thousands of muscle fibres ) . Two papers 7072 by the laboratory that wrote the four authority papers reported that two of these molecules ( β amyloid precursor protein transcript and protein ) were not specific to inclusion body myositis but were present in muscle fibres during regeneration in all dis - eased controls ( up to 43 patients in seven disease cate - gories , including polymyositis , dermatomyositis , Duchenne muscular dystrophy , and amyotrophic lat - eral sclerosis ) . These findings weaken the view that abnormal amounts of these molecules have any speci - ficity to inclusion body myositis and that they cause degeneration of myofibre in patients with inclusion body myositis . One of these papers reported that all three molecules , including β amyloid , were produced by muscle invading macrophages in inclusion body myositis and all other inflammatory myopathies , 70 offering an alternative source than myofibre produc - tion for them and indicating that β amyloid was non - specifically present in other inflammatory myopathy muscle ( see web extra note 6 for a detailed discussion of these papers ) . To understand why supportive but not critical data achieved authority over the ensuing 12 years since publication of all of these data , the number of citations received by each paper was analysed ( fig 2 ) . The sup - portive papers received 94 % of the 214 citations to these primary data , whereas the six papers containing data that weakened or refuted the claim received only 6 % of these citations ( differing citation frequency , P = 0 . 01 ) . Citation bias , here defined as statistically sig - nificant differences in the number of citations received among primary data papers , seemed to be specifically against critical data not the laboratory producing it , as two papers 7072 thatwere biasedagainst werewrittenby the same research group that wrote four of the highly cited supportive papers . For example , one of the papers 70 addresses a crucial question in the specialty , the relation between inflammation and degeneration , 1 - 39 but reported data that potentially conflicted with the belief that β amyloid is produced by inclusion body myositis myofibres or is uniquely present in inclusion body myositis muscle ( reporting that β amyloid is produced by muscle invading macro - phages in all inflammatory myopathies ) . These data have never been cited by their authors despite them having made 104 citations about β amyloid to other primary data papers . Citation bias to justify models Citation bias has also been used to claim that animal and cell culture experiments are valid models of inclu - sionbodymyositis , in17papers . 81 - 97 Ofthe32citations to primary data from these papers , 31 ( 97 % ) flowed to the four highly supportive papers , 74757980 whereas only one citation ( 3 % ) was made to any of the six papers that presented data weakening or refuting these as valid models for inclusion body myositis ( fig 3 ) . For exam - ple , one paper 83 cited another 74 in support of “ abnor - mal accumulation of A β - containing inclusions are present in skeletal muscle of IBM patients ” but not papers that found no 71 or little 7377 β amyloid protein . Similarly , the same paper 83 cited a paper 75 in support of “ there is evidence that APP [ amyloid precursor pro - tein ] mRNA levels are selectively enhanced in human IBM [ inclusion body myositis ] samples thereby pro - viding physiological justification for the overexpres - sion of this protein in transgenic mice , ” but not the paper 73 that found no β amyloid precursor protein mRNA or the paper , 72 by the same authors as the paper , 75 that found β amyloid precursor protein mRNA not “ selectively enhanced ” in inclusion body myositisbutpresentinmusclefibresinall othermuscle diseases examined . The uncited data 72 suggest that the animal and cell culture experiments are no more mod - els of inclusion body myositis than any other neuro - muscular disease in which muscle regeneration occurs . Citation diversion Some papers cited content but distorted it . This is not citation bias , as papers are cited , but rather a different process called here “ citation diversion ”— that is , the citing of content but the altering of its meaning in a manner that diverts its implications . One primary data paper 77 reported no β amyloid precursor protein or β amyloid in three of five patients with inclusion body myositis and its presence in only a “ few fibres ” in the remaining two patients . Three Paper reference N o o f c i t a t i o n s r e c e i v e d C 70 0 20 30 40 50 60 70 10 C 71 C 72 C 73 S 74 S 75 C 77 C 78 S 79 S 80 S = Supportive data C = Critical data = Same research group Fig 2 | Citation bias against content critical of claim . Shown are citation frequencies to four authoritative supportive primary data papers and six primary data papers 70 - 7577 - 80 containing data critical of claim RESEARCH BMJ | ONLINE FIRST | bmj . com page 3 of 14 papers 283738 cited these data ( fig 1 ) reporting that they “ confirmed ” the claim ( for example , one paper 38 said “ β APP 7677 in s - IBM fibers has been confirmed by others ” ) . Whether such data confirm the claim is per - haps open to interpretation . At the least these data are exaggerated and generalised into a view that β amyloid precursor protein is “ accumulated in vacuolated mus - cle fibers of s - IBM patients 77 [ other ] ” as stated by one paper , 28 supported by an erroneous citation because three patients in the paper 77 had 1 . 4 % to 5 % of their myofibres vacuolated but all lacked β amyloid precur - sor protein . Over the ensuing 10 years , these three sup - portive citations developed into 7848 supportive citation paths — chains of false claim in the network cre - ated by citation diversion . In another example of citation diversion one paper 81 stated “ Thus , it has been widely accepted that intra - cellular accumulation of β APP , A β [ β amyloid ] and other β APP proteolytic fragments play an important role in the pathogenesis of IBM , 8689 ” although one of the papers 89 had not widely accepted this claim , stating “ A β - intracellular deposition may be an epiphenome - non unrelated to myofiber death . ” Amplification through influential papers and citations Between 1996 and 2007 support for the claim grew exponentially , with the number of supportive citations andcitationpathsincreasingsevenfoldand777 - fold , to 636 citations and 220 553 citation paths . In contrast , the critical view grew to only 21 citations and 28 cita - tion paths ( fig 4 ) . No papers refuted or critiqued the critical data , but instead the data were just ignored . Analysis of a claim specific citation network can iden - tify exactly which papers and citations have been most influential in pushing forward belief 304305 ( see web extra note 7 ) . The increased support was facilitated by a small number of papers , not reporting any pri - mary data , throughwhich large amounts of traffic ( cita - tionpaths ) flow inthe network . Forexample , 63 % of all citation paths ( n = 139391 ) flow through one review paper 21 ( compared with 2 % of citation paths flowing through randomly selected other papers ) ; 95 % of all citation paths flow through four review papers 16182137 by the same research group ( 8 % through four ran - domly selected other papers ) . A lens effect was present in which a small number of these influential review papers and model papers con - taining no data on claim validity collected and focused citation ( similar to a magnifying lens collecting light ) on particular primary data papers supportive of the belief , while isolating others that weakened it ( fig 4 ) . Such papers have a network property known as high betweenness centrality . 304 The term amplification can be used to describe the expansion of a claim ’ s belief system by citation to paperslackinganydataaddressingit , thephenomenon observed here . Amplification is not inherent to pub - lished belief systems . Authors could choose to cite only primary data when making claims , resulting in amplification minimal networks . Amplification of a claim is instead introduced into belief systems through the citing of review papers and other papers that lack data addressing the claim . Certainly such papers may be cited for other reasons ; amplification only arises when they are cited to support claims of experimental results reported elsewhere . ( See web extra note 8 for further discussion of amplification and methods for quantifying it . ) Network authority emerges through bias against critical content and amplification Papers may be biased against for many potential rea - sons . To examine the role of bias exclusively against critical content in establishing authority , a simulated network was constructed in which all statements mak - ing a supportive claim were amended to recognise cri - tical views of equivalent content and temporal availability . Removing bias against critical content was sufficient to result in authority status for five of the six infrequently cited primary data papers ( fig 4 ) , indicating that authority status of the claim emerges from the citation bias against critical content . The claim cannot be both true and false ; the resulting balanced authority of supportive and refuting papers indicates that without citation bias there would be balanced belief in its truth and falseness ( see web extra note 9 ) . Year Citations 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 = Supportive = Neutral = Critical = Animal / cell culture model = Primary data Supportive data Critical data 1994 1993 1992 Fig 3 | Citations from animal and cell culture model papers to primary data papers supporting rationale for overproduction of β amyloid precursor protein mRNA as a valid model of inclusion body myositis . Only one of 32 citations flows to papers 70 - 737778 that present data that conflict with the validity of these models RESEARCH page 4 of 14 BMJ | ONLINE FIRST | bmj . com Invention Distinct from citation bias and amplification , certain types of fact developed and spread through the belief system . These particular facts were not those that arose from restatement of published claims , but rather involved different mechanisms either deliberate or through scholarly negligence , herein called invention . For example , a subclaim ( that the accumulation of β amyloid occurs early and precedes other abnormal - ities ) has variously been stated as hypothesis , likeli - hood , or fact in 27 papers supported by 37 citations ( see web extra note 10 ) . Nine of these citations ( 24 % ) , used to supporttext making theseclaims , in factflowed to papers that contained no statement on the temporal relation of β amyloid to other abnormalities in inclu - sion body myositis muscle ( dead end citations ) . This subclaim had transformed from hypothesis to “ fact ” through citation alone , a process that might be called citation transmutation ( fig 5 ) . Thus one paper 5 con - tained it as fact ( “ The appearance of A β - positive , non - congophilic deposits precedes vacuolization in IBM muscle fibers 80 ” ) supporting this statement by citing the paper 80 where it had only been proposed as hypothesis ( “ may represent early changes of IBM ” ) . Similarly , another paper 134 reported this as fact ( “ our previous studies demonstrated that abnormalities of β APP precede other changes including congophilia 7480141 ” ) even though the cited papers sta - ted it only as hypothesis 7480 or made no statement at all 141 about the accumulation of β amyloid precursor protein preceding other abnormalities . In another form of invention , claims are introduced as factthrougha “ back door ” thatbypassespeer review and publication of methods and data . This is accom - plished by repeated misrepresentation of abstracts as papers ( seven different papers , 17 citations to 12 different misrepresented abstracts ; for example , cita - tion to Neurol 2003 ; 60 : 333 - 334 , an abstract with cor - rect listing Neurol 2003 ; 60 ( suppl 1 ) : A333 - 4 ; see web extra note 11 ) . The claim that “ β - amyloid 42 isoform [ is ] more common than β - amyloid 40 ” 4 is supported in this manner and accepted by peers as fact ( paper 2 states this citing paper 4 ) ( see web extra note 12 for another form of invention called title invention ) . Bias and invention in National Institutes of Health funded research proposals Through the publication of scientific papers and the demonstrationofthesepublicationsasevidenceofpro - ductivity , the elements of bias , amplification , and invention can be used indirectly to support requests for research funding . To determine if these mechan - isms were used directly to support such requests , the claim specific citation network was extended from the PubMed indexed literature into the research sections and bibliographies of National Institutes of Health funded grant proposals containing text addressing the claim , obtained under the Freedom of Information Act according to National Institutes of Health policy . 310 Of 27 grant proposals requested ( identified through searches of the National Institutes of Health CRISP database as described in web extra note 13 ) , nine were released by the National Institutes of Health . These seemed to be the proposals most pertinent to the belief system . Citation bias or invention was present in eight of nine of these proposals ( fig 6 ) . Of 23 citations to pri - mary data ( not counting multiple citations from one proposaltoasinglepaper ) addressingtheclaim ’ svalid - ity , 20 were made to supportive primary data ( 19 sup - portive citations and one neutral citation ) , two were instances of citation diversion ( one paper 77 again Citations Papers = Supportive = Supportive = Supportive = Supportive = Neutral Models Models Critical primary data Supportive primary data Reviews ReviewsReviewsReviewsReviews Simulatednetwork ReviewsReviewsReviewsReviews = Critical = Authority = Authority = Authority = Authority = Hub = Both Year N o o f c i t a t i o n p a t h s 1990 1994 1998 2002 2006 0 50 000 100 000 150 000 200 000 250 000 Supportive paths Critical paths Fig 4 | Amplification and authority of claim . ( Left ) Historical growth of supportive and critical citations in network . ( Middle ) Rearrangement of network ( fig 1 ) to visualise a lens effect in which eight key papers ( surrounded by ovals ; seven by same research group ; 97 % of all network traffic passes through them ) create citation flows among each other , and both amplify claim and focus citations to supportive data papers . Net effect results in network authority status 306 ( yellow ) of supportive data papers . ( Right ) Computational elimination of citation bias results in balanced authority of both support for claim and its refutation through additional recognition of critical data papers 70 - 7377 as authorities RESEARCH BMJ | ONLINE FIRST | bmj . com page 5 of 14 cited for supporting the claim when it weakens it ) , and one was made to critical content . Invention of fact sup - ported through citation to hypothesis , dead end cita - tion , and abstracts misrepresented as papers were similarly present in these funded proposals . These were sometimes used directly to justify requests for funding of the proposed studies ( for example , “ The accumulation of epitopes of β APP is an early event in the disease relative to the other changes , 3796 justifying our focused investigation of A β ” ; one paper 37 stated this only as hypothesis ; the other paper 96 stated this as likelihood not fact , supporting that view also through citation to the other paper , 37 stated as hypoth - esis ( see web extra note 13 for further discussion ) . DISCUSSION Citation , the act of connecting text statements through reference to the broader literature , is not simply an impartial scholarly method for joining related pub - lishedknowledge . Citationmaybeusedforselfserving purposes 311 or as a tool for persuasion 312 ( see web extra note 14 ) . These aspects of citation might be called social citation . I studied how distortions of the persua - sive aspect of social citation may result in broad accep - tance of unfounded claims as fact . These distortions can be detected and interpreted through social net - worktheory 309 becausecitation aspersuasionis asocial behaviour . Network theory applied to citation net - works constructed from entire paper bibliographies , such as the science citation network , 313 can disclose societal attitudes to journals and specific papers ( for example , impact factors ) , but these networks are not suitable for understanding the foundation for belief in specific claims . When networks are instead confined to citation pertaining to one set of related claims ( a claim specific citation network ) , they become sharply focused tools for understanding social communication pertainingtotheclaims — whatisineffectthepublished record of a belief system shared by a community . These allow for study of not just what is said about a belief ( the traditional scope of review papers ) , but also who hears it and how it is retold . The general approach taken here ( fig 7 ) addressed belief in claims ; no experiments were done addressing their truth . The computational analysis of the claim specific citation network representing this belief sys - tem detected certain distortions in the patterns of cita - tion that would not have been expected had only scholarly citation been used . Primary data that wea - kened or refuted claims on which the belief was based were ignored ( citation bias ) and a small number of influential papers and citations exponentially ampli - fied supportive claim over time without presenting new primary data ( amplification ) . Certain related claims were invented as fact . The combined effects of these citation distortions resulted in authority of the belief ( acceptance of it ) according to social network theory . There are varied forms and consequences of dis - torted persuasive citation seen in this study ( see box ) . Citation bias against critical content can be used for the systematic support of claim , 314 results in the loss of implications of isolated data ( see web extra note 15 ) , and can be used to justify construction of animal mod - els , which can then be circularly used to amplify claim ( see web extra note 16 ) . Such animal models have enormous appeal , and some publications describing them achieved authority status in this network ( fig 1 ) Year Citations 20072006 2005 20042003 20022001 2000 19991998 1997 1996 1995 1994 1993 1992 = Primary data = Grant proposal = Supportive = Neutral = Critical = Diversion Supportive data Critical data Fig 6 | Extension of PubMed claim specific citation network into National Institutes of Health funded research proposals . Nine funded research grants ( G1 - G9 ; see web extra note 13 ) contain statements and citations addressing claim ; their citations to primary data are shown . Citation bias and citation diversion are present = Hypothesis = Likelihood = Fact = No statement = Ambiguous Year 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 Primary data 1994 1993 1992 Fig 5 | Conversion of hypothesis to fact through citation alone . Citations on statement that accumulation of β amyloid “ precedes ” other abnormalities in inclusion body myositis muscle . Statement as fact is supported through citation to papers that only state it as hypothesis ( for example , references 5 to 80 , 91 to 80 , 134 to 74 ) or sometimes supported by citation to papers that contain no statements addressing it ( for example , references 91 to 72 , 251 to 75 ; dead end citations ) . This phenomenon might be called citation transmutation ( see web extra note 10 for statements ) RESEARCH page 6 of 14 BMJ | ONLINE FIRST | bmj . com despite reporting no data addressingthe claim — that is , whether these β amyloid related molecules are present in human inclusion body myositis muscle . Amplifica - tion involves repetitive citation of review papers or other papers lacking data , often through self citation , features noted previously in a variation of a claim spe - cific citation network . 315 Invention has multiple varia - tions . Three factors may account for how citation distor - tions created authority in this belief system . Foremost is the power of citation through the choice of which papers to cite and which to ignore ( citation bias ) , by citing but distorting content ( citation diversion ) , and by using citation to invent fact ( citation transmutation , dead end citation , and back door invention ) . Second is an inherent property of negative results , which failed to spread through the network . These were not repeatedly cited by their authors in subse - quent papers ( only one instance was present 274 ) as per - haps there was simply nothing further to say about them . Unlike “ positive results ” there is nothing excit - ing to be repeatedly written about how something was notfoundinan experiment . Thustheprogressionfrom data to accepted claim is different within a single paper compared with across many papers in a specialty . Within a single paper readers generally view new claims as false until proved true through convincing methods and results . Across a network of papers , how - ever , the barrier to the propagation of negative results biases claims as being viewed as true until proved false . Thirdly , this belief system is possibly an information cascade ( also called an informational cascade ) , 316317 an entity resulting when people perceive advantage in accepting the prevailing view over any private infor - mation they may have when making choices . Indeed certain mathematical properties of information cas - cades ( preferential attachment ) would be expected to produce a network with properties seen here ( a biased networkwithapowerlaw distributionofnode degrees ; see web extra note 3 ) . Many authors may just not be aware of the critical data , as these data are effectively isolated from the discourse about this claim and not mentioned in any review articles . Although unsound information cascades are in theory fragile and fall apart quickly when exposed , 316 this may not occur in biomedical belief systems , where contradicted claims may persist . 318 Many published biomedical belief systems may be information cascades because repetition of claims is ubiquitous in the biomedical literature . Many are built on sound data , with authors repeating claims after trusting the published expert opinion of their col - leagues . However , there are incentives for generating and joining information cascades regardless of their soundness . Joining an information cascade aids publi - cation as articles have to say something and negative results are biased against . 319 Generating and joining an information cascade may improve the likelihood of obtaining research funding because hypothesis driven research is an essential requirement 320 at many research funding agencies such as the National Insti - tutes of Health , and successful funding generally requires a “ strong hypothesis . . . based on current scientific literature ” 320 — that is , the published belief system of a claim . Chances for successful funding may therefore be increased through joining the cas - cade ( repeating the claim and proposing experimental plans around it ) . In the extension of this citation net - work into text within grant proposals that have been funded by the National Institutes of Health , citation bias , diversion , or invention were often present . Once research funding has been used to join a cascade there are further incentives to interpret results through con - firmation bias ( “ in a way that confirms one ’ s precon - ceptions and to avoid information and interpretations which contradict prior beliefs ” 321 ) to demonstrate suc - cess of the research for subsequent funding . Although joining an information cascade may be an optimal behaviour for some people , it reduces the likelihood that future investigators can discover whether it is sound . 317 Methods for the construction and analysis of com - prehensive claim specific citation networks present challenges and limitations . These include interpreting meaning of text , as people may reasonably interpret Collect papers Extract text / citations Construct network Amplification Authorities Primary data Invention Measure citation bias Compare Remove citation bias Balanced authority Fig 7 | Overview of approach . After construction of the claim specific citation network , a combined manual and computational endeavour , steps on left ( determination of authorities [ yellow papers ] and identification of amplification ) require only computational algorithms ; right half ( identifying which papers contain actual data addressing claim validity and identifying invention ) requires careful reading of paper content . Combining results of authority identification with data identification allows for recognition of citation bias and subsequent steps for its simulated removal and assessment of effects on network RESEARCH BMJ | ONLINE FIRST | bmj . com page 7 of 14 text differently , and understanding the distinct phe - nomena observed ( see web extra note 17 for a discus - sion of these issues ) . In principle many biomedical claims have an associated citation network , the study of which provides a powerful approach to detecting citation bias , amplification , and invention , and under - standing the nature of the authority of the claim . I thank Daniel Rockmore ( Department of Mathematics , Dartmouth College ) ; Daniel Jonah Goldhagen ; Peter Park ( Harvard Medical School ) ; and Einer Elhauge ( Harvard Law School ) , for thoughtful discussions . Anthony Amato ( Harvard Medical School ) carried out validation of extracted text and citations . Funding : SAG is in part supported by National Institutes of Health grants R01NS43471 and R21NS057225 , and Muscular Dystrophy Association grant MDA4353 . These grants did not contain specific aims directly encompassing this research . Competinginterests : SAG had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis . Ethicalapproval : Not required . 1 NeedhamM , MastagliaFL . Inclusionbodymyositis : current pathogeneticconceptsanddiagnosticandtherapeuticapproaches . LancetNeurol 2007 ; 6 : 620 - 631 . 2 NeedhamM , MastagliaFL , GarleppMJ . Geneticsofinclusion - body myositis . MuscleNerve 2007 ; 35 : 549 - 561 . 3 AskanasV , EngelWK . Inclusion - bodymyositis , amultifactorial musclediseaseassociatedwithaging : currentconceptsof pathogenesis . CurrOpinRheumatol 2007 ; 19 : 550 - 559 . 4 AskanasV , EngelWK . Inclusion - bodymyositis : amyodegenerative conformationaldisorderassociatedwithAbeta , proteinmisfolding , andproteasomeinhibition . Neurology 2006 ; 66 ( 2Suppl1 ) : S39 - 48 . 5 MurphyMP , GoldeTE . Inclusion - bodymyositisandAlzheimer disease : twosidesofthesamecoin , ordifferentcurrencies altogether ? Neurology 2006 ; 66 ( 2Suppl1 ) : S65 - 68 . 6 BuxbaumJN . Treatmentandpreventionoftheamyloidoses : canthe lessonslearnedbeappliedtosporadicinclusion - bodymyositis ? Neurology 2006 ; 66 ( 2Suppl1 ) : S110 - 113 . 7 EngelWK , AskanasV . Inclusion - bodymyositis : clinical , diagnostic , andpathologicaspects . Neurology 2006 ; 66 ( 2Suppl1 ) : S20 - 29 . 8 DalakasMC . Inflammatory , immune , andviralaspectsofinclusion - bodymyositis . Neurology 2006 ; 66 ( 2Suppl1 ) : S33 - 38 . 9 DalakasMC . Sporadicinclusionbodymyositis – diagnosis , pathogenesisandtherapeuticstrategies . NatClinPractNeurol 2006 ; 2 : 437 - 447 . 10 MunshiSK , ThanviB , JonnalagaddaSJetal . Inclusionbodymyositis : anunderdiagnosedmyopathyofolderpeople . AgeAgeing 2006 ; 35 : 91 - 94 . 11 AskanasV , EngelWK . Molecularpathologyandpathogenesisof inclusion - bodymyositis . MicroscResTech 2005 ; 67 : 114 - 120 . 12 AskanasV , EngelWK . Sporadicinclusion - bodymyositis : aproposed keypathogeneticroleoftheabnormalitiesoftheubiquitin - proteasomesystem , andproteinmisfoldingandaggregation . Acta Myol 2005 ; 24 : 17 - 24 . 13 OldforsA , LindbergC . Diagnosis , pathogenesisandtreatmentof inclusionbodymyositis . CurrOpinNeurol 2005 ; 18 : 497 - 503 . 14 DalakasMC . Inflammatorydisordersofmuscle : progressin polymyositis , dermatomyositisandinclusionbodymyositis . Curr OpinNeurol 2004 ; 17 : 561 - 567 . 15 AskanasV , EngelWK . Unfoldingstoryofinclusion - bodymyositisand myopathies : roleofmisfoldedproteins , amyloid - beta , cholesterol , andaging . JChildNeurol 2003 ; 18 : 185 - 190 . 16 AskanasV , EngelWK . Proposedpathogeneticcascadeofinclusion - bodymyositis : importanceofamyloid - beta , misfoldedproteins , predisposinggenes , andaging . CurrOpinRheumatol 2003 ; 15 : 737 - 744 . 17 DalakasMC . Understandingtheimmunopathogenesisofinclusion - bodymyositis : presentandfutureprospects . RevNeurol ( Paris ) 2002 ; 158 : 948 - 958 . 18 AskanasV , EngelWK . Inclusion - bodymyositisandmyopathies : differentetiologies , possiblysimilarpathogenicmechanisms . Curr OpinNeurol 2002 ; 15 : 525 - 531 . 19 TawilR , GriggsRC . Inclusionbodymyositis . CurrOpinRheumatol 2002 ; 14 : 653 - 657 . 20 AskanasV , EngelWK . Newestpathogeneticconsiderationsin inclusion - bodymyositis : possibleroleofamyloid - beta , cholesterol , relationtoagingandtoAlzheimer ’ sdisease . CurrRheumatolRep 2002 ; 4 : 427 - 433 . 21 AskanasV , EngelWK . Inclusion - bodymyositis : newestconceptsof pathogenesisandrelationtoagingandAlzheimerdisease . J NeuropatholExpNeurol 2001 ; 60 : 1 - 14 . 22 OldforsA , FyhrIM . Inclusionbodymyositis : geneticfactors , aberrant proteinexpression , andautoimmunity . CurrOpinRheumatol 2001 ; 13 : 469 - 475 . 23 OldforsA , LindbergC . Inclusionbodymyositis . CurrOpinNeurol 1999 ; 12 : 527 - 533 . 24 CherinP . Treatmentofinclusionbodymyositis . CurrOpinRheumatol 1999 ; 11 : 456 - 461 . WHAT IS ALREADY KNOWN ON THIS TOPIC In addition to its scholarly use , citation has social uses , both self serving and as a tool for persuasion One distortion of this persuasive aspect of citation , citation bias , has been recognised in clinical trial reporting where it may lead to false belief about a therapy ’ s efficacy WHAT THIS STUDY ADDS Distortions in the persuasive use of citation — bias , amplification , and invention — can be used to establish unfounded scientific claims as fact Categorising these distorted uses of citation and having vocabulary for them aids in their recognition How scientific data evolve into entire published biomedical belief systems around specific claims can bestudiedthrough adevice calleda claim specificcitation network and the useof social network theory Vocabulary of citation distortions Citation Both scholarly and social forms : the scholarly form connects statements to the broader medical literature , the social form ( social citation ) includes self serving and persuasive subtypes Citation distortions Self serving citation is always a distortion Persuasive citation may be necessary to communicate new , sound claims to the scientific community ; it may , however , have distorted uses — citation bias , amplification , and invention Citation bias Systematic ignoring of papers that contain content conflicting with a claim Bolster claim ; justifying animal models to provide opportunities to amplify claim Amplification Expansion of a belief system without data Citation made to papers that don ’ t contain primary data , increasing the number of citations supporting the claim without presenting data addressing it Invention Citation diversion — citing contentbut claiming ithas a differentmeaning , thereby diverting its implications Citation transmutation — the conversion of hypothesis into fact through the act of citation alone Back door invention — repeated misrepresentation of abstracts as peer reviewed papers to fool readers into believing that claims arebased on peer reviewed published methods and data Dead end citation — support of a claim with citation to papers that do not contain content addressing the claim Title invention — reportingof “ experimentalresults ” in apaper ’ s title , eventhoughthepaper does not report the performance or results of any such experiments RESEARCH page 8 of 14 BMJ | ONLINE FIRST | bmj . com 25 VogelH . Inclusionbodymyositis – areview . AdvAnatPathol 1998 ; 5 : 164 - 169 . 26 AskanasV , EngelWK . Sporadicinclusion - bodymyositisand hereditaryinclusion - bodymyopathies : currentconceptsofdiagnosis andpathogenesis . CurrOpinRheumatol 1998 ; 10 : 530 - 542 . 27 AskanasV , EngelWK . DoesoverexpressionofbetaAPPinaging musclehaveapathogenicroleandarelevancetoAlzheimer ’ s disease ? Cluesfrominclusionbodymyositis , culturedhuman muscle , andtransgenicmice . AmJPathol 1998 ; 153 : 1673 - 1677 . 28 AskanasV , EngelWK . Sporadicinclusion - bodymyositisandits similaritiestoAlzheimerdiseasebrain . Recentapproachesto diagnosisandpathogenesis , andrelationtoaging . ScandJ Rheumatol 1998 ; 27 : 389 - 405 . 29 AskanasV , EngelWK . Sporadicinclusion - bodymyositisand hereditaryinclusion - bodymyopathies : diseasesofoxidativestress andaging ? ArchNeurol 1998 ; 55 : 915 - 920 . 30 AskanasV , EngelWK , AlvarezRB . Fourteennewlyrecognized proteinsatthehumanneuromuscularjunctions – andtheir nonjunctionalaccumulationininclusion - bodymyositis . AnnNY AcadSci 1998 ; 841 : 28 - 56 . 31 IllaI , DalakasMC . Dermatomyositis , polymyositisandinclusionbody myositis : currentconcepts . RevNeurol ( Paris ) 1998 ; 154 : 13 - 16 . 32 SivakumarK , DalakasMC . Inclusionbodymyositisandmyopathies . CurrOpinNeurol 1997 ; 10 : 413 - 420 . 33 DalakasMC , SivakumarK . Theimmunopathologicandinflammatory differencesbetweendermatomyositis , polymyositisandsporadic inclusionbodymyositis . CurrOpinNeurol 1996 ; 9 : 235 - 239 . 34 GarleppMJ , MastagliaFL . Inclusionbodymyositis . JNeurol NeurosurgPsychiatry 1996 ; 60 : 251 - 255 . 35 CarpenterS . Inclusionbodymyositis , areview . JNeuropatholExp Neurol 1996 ; 55 : 1105 - 1114 . 36 GriggsRC , AskanasV , DiMauroSetal . Inclusionbodymyositisand myopathies . AnnNeurol 1995 ; 38 : 705 - 713 . 37 AskanasV , EngelWK . Newadvancesintheunderstandingof sporadicinclusion - bodymyositisandhereditaryinclusion - body myopathies . CurrOpinRheumatol 1995 ; 7 : 486 - 496 . 38 AskanasV , EngelWK , MirabellaM . Idiopathicinflammatory myopathies : inclusion - bodymyositis , polymyositis , and dermatomyositis . CurrOpinNeurol 1994 ; 7 : 448 - 456 . 39 CalabreseLH , ChouSM . Inclusionbodymyositis . RheumDisClin NorthAm 1994 ; 20 : 955 - 972 . 40 ChouSM . Inclusionbodymyositis . BaillieresClinNeurol 1993 ; 2 : 557 - 577 . 41 AskanasV , EngelWK . Newadvancesininclusion - bodymyositis . Curr OpinRheumatol 1993 ; 5 : 732 - 741 . 42 SekulEA , DalakasMC . Inclusionbodymyositis : newconcepts . SeminNeurol 1993 ; 13 : 256 - 263 . 43 BrianiC , DoriaA , Sarzi - PuttiniP , DalakasMC . Updateonidiopathic inflammatorymyopathies . Autoimmunity 2006 ; 39 : 161 - 170 . 44 DalakasMC . Therapeutictargetsinpatientswithinflammatory myopathies : presentapproachesandalooktothefuture . NeuromusculDisord 2006 ; 16 : 223 - 236 . 45 DalakasMC . Mechanismsofdisease : signalingpathwaysand immunobiologyofinflammatorymyopathies . NatClinPract Rheumatol 2006 ; 2 : 219 - 227 . 46 DalakasMC . Thefutureprospectsintheclassification , diagnosisand therapiesofinflammatorymyopathies : aviewtothefuturefromthe “ bench - to - bedside ” . JNeurol 2004 ; 251 : 651 - 657 . 47 ChinoyH , OllierWE , CooperRG . Haverecentimmunogenetic investigationsincreasedourunderstandingofdiseasemechanismsintheidiopathicinflammatorymyopathies ? CurrOpinRheumatol 2004 ; 16 : 707 - 713 . 48 Christopher - StineL , PlotzPH . Myositis : anupdateonpathogenesis . CurrOpinRheumatol 2004 ; 16 : 700 - 706 . 49 Christopher - StineL , PlotzPH . Adultinflammatorymyopathies . Best PractResClinRheumatol 2004 ; 18 : 331 - 344 . 50 DalakasMC . Themolecularpathophysiologyininflammatory myopathies . RevMedInterne 2004 ; 25Suppl1 : S14 - 16 . 51 Figarella - BrangerD , CivatteM , BartoliC , PellissierJF . Cytokines , chemokines , andcelladhesionmoleculesininflammatory myopathies . MuscleNerve 2003 ; 28 : 659 - 682 . 52 MastagliaFL , GarleppMJ , PhillipsBA , ZilkoPJ . Inflammatory myopathies : clinical , diagnosticandtherapeuticaspects . Muscle Nerve 2003 ; 27 : 407 - 425 . 53 DalakasMC . Therapeuticapproachesinpatientswithinflammatory myopathies . SeminNeurol 2003 ; 23 : 199 - 206 . 54 DalakasMC . Musclebiopsyfindingsininflammatorymyopathies . RheumDisClinNorthAm 2002 ; 28 : 779 - 798 . 55 KisselJT . Misunderstandings , misperceptions , andmistakesinthe managementoftheinflammatorymyopathies . SeminNeurol 2002 ; 22 : 41 - 51 . 56 Hilton - JonesD . Inflammatorymusclediseases . CurrOpinNeurol 2001 ; 14 : 591 - 596 . 57 DalakasMC . Molecularimmunologyandgeneticsofinflammatory musclediseases . ArchNeurol 1998 ; 55 : 1509 - 1512 . 58 BertoriniTE . Inflammatorymyopathies [ polymyositis , dermatomyositis , inclusionbodymyositis ] . ComprTher 1998 ; 24 : 494 - 502 . 59 MantegazzaR , BernasconiP , ConfalonieriP , CornelioF . Inflammatory myopathiesandsystemicdisorders : areviewof immunopathogeneticmechanismsandclinicalfeatures . JNeurol 1997 ; 244 : 277 - 287 . 60 AmatoAA , BarohnRJ . Idiopathicinflammatorymyopathies . Neurol Clin 1997 ; 15 : 615 - 648 . 61 SerratriceG . Thethreegroupsofpolymyositis . RevRhumEnglEd 1996 ; 63 : 797 - 800 . 62 DalakasMC . Immunopathogenesisofinflammatorymyopathies . AnnNeurol 1995 ; 37 ( suppl1 ) : S74 - S86 . 63 MantegazzaR , BernasconiP . Cellularaspectsofmyositis . CurrOpin Rheumatol 1994 ; 6 : 568 - 574 . 64 DalakasMC . Currenttreatmentoftheinflammatorymyopathies . Curr OpinRheumatol 1994 ; 6 : 595 - 601 . 65 KarpatiG , CarpenterS . Pathologyoftheinflammatorymyopathies . BaillieresClinNeurol 1993 ; 2 : 527 - 556 . 66 DalakasMC . Clinical , immunopathologic , andtherapeutic considerationsofinflammatorymyopathies . ClinNeuropharmacol 1992 ; 15 : 327 - 351 . 67 KalovidourisAE . Immuneaspectsofmyositis . CurrOpinRheumatol 1992 ; 4 : 809 - 814 . 68 DalakasMC . Inflammatoryandtoxicmyopathies . CurrOpinNeurol Neurosurg 1992 ; 5 : 645 - 654 . 69 LunemannJD , SchmidtJ , SchmidDetal . Beta - amyloidisasubstrate ofautophagyinsporadicinclusionbodymyositis . AnnNeurol 2007 ; 61 : 476 - 483 . 70 AskanasV , SarkoziE , BilakMetal . Humanmusclemacrophages expressbeta - amyloidprecursorandprionproteinsandtheirmRNAs . Neuroreport 1995 ; 6 : 1045 - 1049 . 71 SherriffFE , JoachimCL , SquierMV , EsiriMM . Ubiquitinated inclusionsininclusion - bodymyositispatientsareimmunoreactive forcathepsinDbutnotbeta - amyloid . NeurosciLett 1995 ; 194 : 37 - 40 . 72 SarkoziE , AskanasV , JohnsonSAetal . Expressionofbeta - amyloid precursorproteingeneisdevelopmentallyregulatedinhumanmusclefibersinvivoandinvitro . ExpNeurol 1994 ; 128 : 27 - 33 . 73 NalbantogluJ , KarpatiG , CarpenterS . Conspicuousaccumulationof asingle - strandedDNAbindingproteininskeletalmusclefibersin inclusionbodymyositis . AmJPathol 1994 ; 144 : 874 - 882 . 74 AskanasV , AlvarezRB , EngelWK . beta - Amyloidprecursorepitopesin musclefibersofinclusionbodymyositis . AnnNeurol 1993 ; 34 : 551 - 560 . 75 SarkoziE , AskanasV , JohnsonSAetal . beta - Amyloidprecursor proteinmRNAisincreasedininclusion - bodymyositismuscle . Neuroreport 1993 ; 4 : 815 - 818 . 76 VillanovaM , KawaiM , LubkeUetal . Rimmedvacuolesofinclusion bodymyositisandoculopharyngealmusculardystrophycontainamyloidprecursorproteinandlysosomalmarkers . BrainRes 1993 ; 603 : 343 - 347 . 77 LeclercA , TomeFM , FardeauM . Ubiquitinandbeta - amyloid - protein ininclusionbodymyositis ( IBM ) , familialIBM - likedisorderand oculopharyngealmusculardystrophy : animmunocytochemical study . NeuromusculDisord 1993 ; 3 : 283 - 291 . 78 SchubertW , MastersCL , BeyreutherK . APP + Tlymphocytes selectivelysortedtoendomysialtubesinpolymyositisdisplaceNCAM - expressingmusclefibers . EurJCellBiol 1993 ; 62 : 333 - 342 . 79 AskanasV , EngelWK , AlvarezRB , GlennerGG . beta - Amyloidprotein immunoreactivityinmuscleofpatientswithinclusion - bodymyositis . Lancet 1992 ; 339 : 560 - 561 . 80 AskanasV , EngelWK , AlvarezRB . Lightandelectronmicroscopic localizationofbeta - amyloidproteininmusclebiopsiesofpatients withinclusion - bodymyositis . AmJPathol 1992 ; 141 : 31 - 36 . 81 SugarmanMC , KitazawaM , BakerMetal . Pathogenicaccumulation ofAPPinfasttwitchmuscleofIBMpatientsandatransgenicmodel . NeurobiolAging 2006 ; 27 : 423 - 432 . 82 RosenKM , VeereshwarayyaV , MoussaCEetal . Parkinprotects againstmitochondrialtoxinsandbeta - amyloidaccumulationin skeletalmusclecells . JBiolChem 2006 ; 281 : 12809 - 12816 . 83 KitazawaM , GreenKN , CaccamoA , LaFerlaFM . Genetically augmentingAbeta42levelsinskeletalmuscleexacerbatesinclusionbodymyositis - likepathologyandmotordeficitsintransgenicmice . AmJPathol 2006 ; 168 : 1986 - 1997 . 84 MoussaCE , FuQ , KumarPetal . Transgenicexpressionofbeta - APPin fast - twitchskeletalmuscleleadstocalciumdyshomeostasisand IBM - likepathology . FasebJ 2006 ; 20 : 2165 - 2167 . 85 FrattaP , EngelWK , McFerrinJetal . Proteasomeinhibitionand aggresomeformationinsporadicinclusion - bodymyositisandin amyloid - betaprecursorprotein - overexpressingculturedhuman musclefibers . AmJPathol 2005 ; 167 : 517 - 526 . 86 ChristensenRA , ShtifmanA , AllenPDetal . Calciumdyshomeostasis inbeta - amyloidandtau - bearingskeletalmyotubes . JBiolChem 2004 ; 279 : 53524 - 53532 . RESEARCH BMJ | ONLINE FIRST | bmj . com page 9 of 14 87 StrazielleC , DumontM , FukuchiK , LalondeR . Transgenicmice expressingthehumanC99terminalfragmentofbetaAPP : effectson cytochromeoxidaseactivityinskeletalmuscleandbrain . JChem Neuroanat 2004 ; 27 : 237 - 246 . 88 SugarmanMC , YamasakiTR , OddoSetal . Inclusionbodymyositis - likephenotypeinducedbytransgenicoverexpressionofbetaAPPinskeletalmuscle . ProcNatlAcadSciUSA 2002 ; 99 : 6334 - 6339 . 89 QuerfurthHW , SuharaT , RosenKMetal . Beta - amyloidpeptide expressionissufficientformyotubedeath : implicationsforhuman inclusionbodymyopathy . MolCellNeurosci 2001 ; 17 : 793 - 810 . 90 BaronP , GalimbertiD , MedaLetal . ProductionofIL - 6byhuman myoblastsstimulatedwithAbeta : relevanceinthepathogenesisof IBM . Neurology 2001 ; 57 : 1561 - 1565 . 91 BaronP , GalimbertiD , MedaLetal . Synergisticeffectofbeta - amyloid proteinandinterferongammaonnitricoxideproductionbyC2C12musclecells . Brain 2000 ; 123 : 374 - 379 . 92 McFerrinJ , EngelWK , AskanasV . Culturedinclusion - bodymyositis musclefibersdonotaccumulatebeta - amyloidprecursorproteinand canbeinnervated . Neurology 1999 ; 53 : 2184 - 2187 . 93 FukuchiK , PhamD , HartMetal . Amyloid - betadepositioninskeletal muscleoftransgenicmice : possiblemodelofinclusionbody myopathy . AmJPathol 1998 ; 153 : 1687 - 1693 . 94 JinLW , HearnMG , OgburnCEetal . Transgenicmiceover - expressing theC - 99fragmentofbetaPPwithanalpha - secretasesitemutation developamyopathysimilartohumaninclusionbodymyositis . AmJ Pathol 1998 ; 153 : 1679 - 1686 . 95 McFerrinJ , EngelWK , AskanasV . Impairedinnervationofcultured humanmuscleoverexpressingbetaAPPexperimentallyandgenetically : relevancetoinclusion - bodymyopathies . Neuroreport 1998 ; 9 : 3201 - 3205 . 96 AskanasV , McFerrinJ , AlvarezRBetal . BetaAPPgenetransferinto culturedhumanmuscleinducesinclusion - bodymyositisaspects . Neuroreport 1997 ; 8 : 2155 - 2158 . 97 AskanasV , McFerrinJ , BaqueSetal . Transferofbeta - amyloid precursorproteingeneusingadenovirusvectorcausesmitochondrialabnormalitiesinculturednormalhumanmuscle . Proc NatlAcadSciUSA 1996 ; 93 : 1314 - 1319 . 98 BanwellBL , EngelAG . AlphaB - crystallinimmunolocalizationyields newinsightsintoinclusionbodymyositis . Neurology 2000 ; 54 : 1033 - 1041 . 99 HutchinsonDO . Inclusionbodymyositis : abnormalprotein accumulationdoesnottriggerapoptosis . Neurology 1998 ; 51 : 1742 - 1745 . 100 PruittJN , 2nd , ShowalterCJ , EngelAG . Sporadicinclusionbody myositis : countsofdifferenttypesofabnormalfibers . AnnNeurol 1996 ; 39 : 139 - 143 . 101 AskanasV , EngelWK , AlvarezRB . Enhanceddetectionofcongo - red - positiveamyloiddepositsinmusclefibersofinclusionbodymyositisandbrainofAlzheimer ’ sdiseaseusingfluorescencetechnique . Neurology 1993 ; 43 : 1265 - 1267 . 102 MendellJR , SahenkZ . Inclusionbodymyositis . Neurology 1992 ; 42 : 2231 - 2232 . 103 NevilleHE , BaumbachLL , RingelSPetal . Familialinclusionbody myositis : evidenceforautosomaldominantinheritance . Neurology 1992 ; 42 : 897 - 902 . 104 MendellJR , SahenkZ , GalesT , PaulL . Amyloidfilamentsininclusion bodymyositis . Novelfindingsprovideinsightintonatureof filaments . ArchNeurol 1991 ; 48 : 1229 - 1234 . 105 WojcikS , NogalskaA , McFerrinJetal . Myostatinprecursorproteinis increasedandassociateswithamyloid - betaprecursorproteinin inclusion - bodymyositisculturemodel . NeuropatholApplNeurobiol 2007 ; 33 : 238 - 242 . 106 WojcikS , EngelWK , YanRetal . NOGOisincreasedandbindsto BACE1insporadicinclusion - bodymyositisandinAbetaPP - overexpressingculturedhumanmusclefibers . ActaNeuropathol ( Berl ) 2007 ; 114 : 517 - 526 . 107 SalajeghehM , RajuR , SchmidtJ , DalakasMC . Upregulationof thrombospondin - 1 ( TSP - 1 ) anditsbindingpartners , CD36andCD47 , insporadicinclusionbodymyositis . JNeuroimmunol 2007 ; 187 : 166 - 174 . 108 WojcikS , EngelWK , McFerrinJetal . AbetaPP - overexpressionand proteasomeinhibitionincreasealphaB - crystallininculturedhuman muscle : relevancetoinclusion - bodymyositis . NeuromusculDisord 2006 ; 16 : 839 - 844 . 109 PacielloO , WojcikS , EngelWKetal . Parkinanditsassociationwith alpha - synucleinandAbetaPPininclusion - bodymyositisand AbetaPP - overexpressingculturedhumanmusclefibers . ActaMyol 2006 ; 25 : 13 - 22 . 110 NogalskaA , EngelWK , McFerrinJetal . Homocysteine - induced endoplasmicreticulumprotein ( Herp ) isup - regulatedinsporadic inclusion - bodymyositisandinendoplasmicreticulumstress - inducedculturedhumanmusclefibers . JNeurochem 2006 ; 96 : 1491 - 1499 . 111 BroccoliniA , GidaroT , MorosettiRetal . Neprilysinparticipatesin skeletalmuscleregenerationandisaccumulatedinabnormal musclefibresofinclusionbodymyositis . JNeurochem 2006 ; 96 : 777 - 789 . 112 LiJ , YinC , OkamotoHetal . Proteomicanalysisofinclusionbody myositis . JNeuropatholExpNeurol 2006 ; 65 : 826 - 833 . 113 WojcikS , EngelWK , McFerrinJ , AskanasV . Myostatinisincreased andcomplexeswithamyloid - betawithinsporadicinclusion - body myositismusclefibers . ActaNeuropathol ( Berl ) 2005 ; 110 : 173 - 177 . 114 FerrerI , CarmonaM , BlancoRetal . Involvementofclusterinandthe aggresomeinabnormalproteindepositsinmyofibrillarmyopathiesandinclusionbodymyositis . BrainPathol 2005 ; 15 : 101 - 108 . 115 FrattaP , EngelWK , VanLeeuwenFWetal . MutantubiquitinUBB + 1is accumulatedinsporadicinclusion - bodymyositismusclefibers . Neurology 2004 ; 63 : 1114 - 1117 . 116 BroccoliniA , RicciE , PescatoriMetal . Insulin - likegrowthfactorIin inclusion - bodymyositisandhumanmusclecultures . JNeuropathol ExpNeurol 2004 ; 63 : 650 - 659 . 117 VattemiG , EngelWK , McFerrinJ , AskanasV . Endoplasmicreticulum stressandunfoldedproteinresponseininclusionbodymyositismuscle . AmJPathol 2004 ; 164 : 1 - 7 . 118 ChoiYC , KimTS , KimSY . Increaseintransglutaminase2inidiopathic inflammatorymyopathies . EurNeurol 2004 ; 51 : 10 - 14 . 119 VattemiG , EngelWK , McFerrinJ , AskanasV . CystatinCcolocalizes withamyloid - betaandcoimmunoprecipitateswithamyloid - beta precursorproteininsporadicinclusion - bodymyositismuscles . J Neurochem 2003 ; 85 : 1539 - 1546 . 120 Jaworska - WilczynskaM , WilczynskiGM , EngelWKetal . Three lipoproteinreceptorsandcholesterolininclusion - bodymyositis muscle . Neurology 2002 ; 58 : 438 - 445 . 121 GreenbergSA , SanoudouD , HaslettJNetal . Molecularprofilesof inflammatorymyopathies . Neurology 2002 ; 59 : 1170 - 1182 . 122 VattemiG , EngelWK , McFerrinJetal . PresenceofBACE1andBACE2 inmusclefibresofpatientswithsporadicinclusion - bodymyositis . Lancet 2001 ; 358 : 1962 - 1964 . 123 WilczynskiGM , EngelWK , AskanasV . Novelcytoplasmic immunolocalizationofRNApolymeraseIIininclusion - bodymyositis muscle . Neuroreport 2001 ; 12 : 1809 - 1814 . 124 ZanussoG , VattemiG , FerrariSetal . Increasedexpressionofthe normalcellularisoformofprionproteinininclusion - bodymyositis , inflammatorymyopathiesanddenervationatrophy . BrainPathol 2001 ; 11 : 182 - 189 . 125 ChoiY - C , ParkGT , KimT - Setal . Sporadicinclusionbodymyositis correlateswithincreasedexpressionandcross - linkingby transglutaminases1and2 . J . Biol . Chem 2000 ; 275 : 8703 - 8710 . 126 ChoiYC , DalakasMC . Expressionofmatrixmetalloproteinasesinthe muscleofpatientswithinflammatorymyopathies . Neurology 2000 ; 54 : 65 - 71 . 127 WilczynskiGM , EngelWK , AskanasV . Cyclin - dependentkinase5 colocalizeswithphosphorylatedtauinhumaninclusion - body myositispaired - helicalfilamentsandmayplayaroleintau phosphorylation . NeurosciLett 2000 ; 293 : 33 - 36 . 128 KokCC , BoytA , GaudieriSetal . MitochondrialDNAvariantsin inclusionbodymyositis . NeuromusculDisord 2000 ; 10 : 604 - 611 . 129 AskanasV , EngelWK , AlvarezRBetal . Novelimmunolocalizationof alpha - synucleininhumanmuscleofinclusion - bodymyositis , regeneratingandnecroticmusclefibers , andatneuromuscular junctions . JNeuropatholExpNeurol 2000 ; 59 : 592 - 598 . 130 WilczynskiGM , EngelWK , AskanasV . Associationofactive extracellularsignal - regulatedproteinkinasewithpairedhelical filamentsofinclusion - bodymyositismusclesuggestsitsrolein inclusion - bodymyositistauphosphorylation . AmJPathol 2000 ; 156 : 1835 - 1840 . 131 BroccoliniA , EngelWK , AlvarezRB , AskanasV . Redoxfactor - 1in musclebiopsiesofpatientswithinclusion - bodymyositis . Neurosci Lett 2000 ; 287 : 1 - 4 . 132 LiM , DalakasMC . Themusclemitogen - activatedproteinkinaseis alteredinsporadicinclusionbodymyositis . Neurology 2000 ; 54 : 1665 - 1670 . 133 BroccoliniA , EngelWK , AlvarezRB , AskanasV . Pairedhelical filamentsofinclusion - bodymyositismusclecontainRNAand survivalmotorneuronprotein . AmJPathol 2000 ; 156 : 1151 - 1155 . 134 AskanasV , EngelWK , YangCCetal . Lightandelectronmicroscopic immunolocalizationofpresenilin1inabnormalmusclefibersof patientswithsporadicinclusion - bodymyositisandautosomal - recessiveinclusion - bodymyopathy . AmJPathol 1998 ; 152 : 889 - 895 . 135 YangCC , AskanasV , EngelWK , AlvarezRB . Immunolocalizationof transcriptionfactorNF - kappaBininclusion - bodymyositismuscle andatnormalhumanneuromuscularjunctions . NeurosciLett 1998 ; 254 : 77 - 80 . 136 Semino - MoraC , DalakasMC . Rimmedvacuoleswithbeta - amyloid andubiquitinatedfilamentousdepositsinthemusclesofpatients withlong - standingdenervation ( postpoliomyelitismuscular atrophy ) : similaritieswithinclusionbodymyositis . HumPathol 1998 ; 29 : 1128 - 1133 . RESEARCH page 10 of 14 BMJ | ONLINE FIRST | bmj . com 137 YangCC , AlvarezRB , EngelWK , AskanasV . Increaseofnitricoxide synthasesandnitrotyrosineininclusion - bodymyositis . Neuroreport 1996 ; 8 : 153 - 158 . 138 MirabellaM , AlvarezRB , EngelWKetal . ApolipoproteinEand apolipoproteinEmessengerRNAinmuscleofinclusionbodymyositisandmyopathies . AnnNeurol 1996 ; 40 : 864 - 872 . 139 SarkoziE , AskanasV , EngelWK . Abnormalaccumulationofprion proteinmRNAinmusclefibersofpatientswithsporadicinclusion - bodymyositisandhereditaryinclusion - bodymyopathy . AmJPathol 1994 ; 145 : 1280 - 1284 . 140 AskanasV , MirabellaM , EngelWKetal . ApolipoproteinE immunoreactivedepositsininclusion - bodymusclediseases . Lancet 1994 ; 343 : 364 - 365 . 141 AskanasV , EngelWK , BilakMetal . Twistedtubulofilamentsof inclusionbodymyositismuscleresemblepairedhelicalfilamentsofAlzheimerbrainandcontainhyperphosphorylatedtau . AmJPathol 1994 ; 144 : 177 - 187 . 142 AskanasV , BilakM , EngelWKetal . Prionproteinisabnormally accumulatedininclusion - bodymyositis . Neuroreport 1993 ; 5 : 25 - 28 . 143 BilakM , AskanasV , EngelWK . Strongimmunoreactivityofalpha1 - antichymotrypsinco - localizeswithbeta - amyloidproteinand ubiquitininvacuolatedmusclefibersofinclusion - bodymyositis . ActaNeuropathol ( Berl ) 1993 ; 85 : 378 - 382 . 144 GreenbergSA . Ageneexpressionapproachtostudyperturbed pathwaysinmyositis . CurrOpinRheumatol 2007 ; 19 : 536 - 541 . 145 KimonisVE , WattsGD . Autosomaldominantinclusionbody myopathy , Pagetdiseaseofbone , andfrontotemporaldementia . AlzheimerDisAssocDisord 2005 ; 19Suppl1 : S44 - 47 . 146 NogalskaA , WojcikS , EngelWKetal . Endoplasmicreticulumstress inducesmyostatinprecursorproteinandNF - kappaBincultured humanmusclefibers : relevancetoinclusionbodymyositis . Exp Neurol 2007 ; 204 : 610 - 618 . 147 MalicdanMC , NoguchiS , NonakaIetal . AGNEknockoutmouse expressinghumanV572Lmutationdevelopsfeaturessimilartodistalmyopathywithrimmedvacuolesorhereditaryinclusionbodymyopathy . HumMolGenet 2007 ; 16 : 115 - 128 . 148 MorosettiR , MirabellaM , GliubizziCetal . MyoDexpressionrestores defectivemyogenicdifferentiationofhumanmesoangioblastsfrominclusion - bodymyositismuscle . ProcNatlAcadSciUSA 2006 ; 103 : 16995 - 17000 . 149 ChahinN , EngelAG . Correlationofmusclebiopsy , clinicalcourse , andoutcomeinPMandsporadicIBM . Neurology 2008 ; 70 : 418 - 24 . 150 HuangS , LiangJ , ZhengMetal . Inducibleoverexpressionofwild - type prionproteininthemusclesleadstoaprimarymyopathyintransgenicmice . ProcNatlAcadSciUSA 2007 ; 104 : 6800 - 6805 . 151 DalakasMC , RakocevicG , ShatunovAetal . Inclusionbodymyositis withhumanimmunodeficiencyvirusinfection : fourcaseswithclonal expansionofviral - specificTcells . AnnNeurol 2007 ; 61 : 466 - 475 . 152 HadjivassiliouM , ChattopadhyayAK , GrunewaldRAetal . Myopathy associatedwithglutensensitivity . MuscleNerve 2007 ; 35 : 443 - 450 . 153 WeihlCC , MillerSE , HansonPI , PestronkA . Transgenicexpressionof inclusionbodymyopathyassociatedmutantp97 / VCPcauses weaknessandubiquitinatedproteininclusionsinmice . HumMol Genet 2007 ; 16 : 919 - 928 . 154 HatanakaY , OhSJ . Single - fiberelectromyographyinsporadic inclusionbodymyopathy . ClinNeurophysiol 2007 ; 118 : 1563 - 1568 . 155 FinchCE . Aperspectiveonsporadicinclusion - bodymyositis : therole ofagingandinflammatoryprocesses . Neurology 2006 ; 66 ( 2Suppl1 ) : S1 - 6 . 156 GlabeCG , KayedR . Commonstructureandtoxicfunctionofamyloid oligomersimpliesacommonmechanismofpathogenesis . Neurology 2006 ; 66 ( 2Suppl1 ) : S74 - 78 . 157 VetrivelKS , ThinakaranG . Amyloidogenicprocessingofbeta - amyloid precursorproteininintracellularcompartments . Neurology 2006 ; 66 ( 2Suppl1 ) : S69 - 73 . 158 MoreiraPI , HondaK , ZhuXetal . Brainandbrawn : parallelsin oxidativestrength . Neurology 2006 ; 66 ( 2Suppl1 ) : S97 - 101 . 159 ZhangK , KaufmanRJ . Theunfoldedproteinresponse : astress signalingpathwaycriticalforhealthanddisease . Neurology 2006 ; 66 ( 2Suppl1 ) : S102 - 109 . 160 KoistinenH , PrinjhaR , SodenPetal . Elevatedlevelsofamyloid precursorproteininmuscleofpatientswithamyotrophiclateralsclerosisandamousemodelofthedisease . MuscleNerve 2006 ; 34 : 444 - 450 . 161 FidzianskaA , GlinkaZ . Rimmedvacuoleswithbeta - amyloidandtau proteindepositsinthemuscleofchildrenwithhereditarymyopathy . ActaNeuropathol ( Berl ) 2006 ; 112 : 185 - 193 . 162 DimitriD , BenvenisteO , DubourgOetal . Sharedbloodandmuscle CD8 + T - cellexpansionsininclusionbodymyositis . Brain 2006 ; 129 : 986 - 995 . 163 McGavernDB . Immunotherapeuticrelieffrompersistentinfections andamyloiddisorders . Neurology 2006 ; 66 ( 2Suppl1 ) : S59 - 64 . 164 SteinmanL . Controllingautoimmunityinsporadicinclusion - body myositis . Neurology 2006 ; 66 ( 2Suppl1 ) : S56 - 58 . 165 OldforsA , MoslemiAR , JonassonLetal . Mitochondrialabnormalities ininclusion - bodymyositis . Neurology 2006 ; 66 ( 2Suppl1 ) : S49 - 55 . 166 GhettiB , GoebelHH . Frontotemporaldementia : thepost - tauera . Neurology 2006 ; 67 : 560 - 561 . 167 WeihlCC , DalalS , PestronkA , HansonPI . Inclusionbodymyopathy - associatedmutationsinp97 / VCPimpairendoplasmicreticulum - associateddegradation . HumMolGenet 2006 ; 15 : 189 - 199 . 168 DeBleeckerJL , CreusKK , DePaepeB . Potentialtherapeutictargets foridiopathicinflammatorymyopathies . DrugNewsPerspect 2006 ; 19 : 549 - 557 . 169 AuthierFJ , ChariotP , GherardiRK . Skeletalmuscleinvolvementin humanimmunodeficiencyvirus ( HIV ) - infectedpatientsintheeraof highlyactiveantiretroviraltherapy ( HAART ) . MuscleNerve 2005 ; 32 : 247 - 260 . 170 DalakasMC . Autoimmunemuscularpathologies . NeurolSci 2005 ; 26 ( Suppl1 ) : S7 - 8 . 171 KrivickasLS , AmatoAA , KrishnanGetal . Preservationofinvitro musclefiberfunctionindermatomyositisandinclusionbodymyositis : asinglefiberstudy . NeuromusculDisord 2005 ; 15 : 349 - 354 . 172 Ranque - FrancoisB , MaisonobeT , DionEetal . Familialinflammatory inclusionbodymyositis . AnnRheumDis 2005 ; 64 : 634 - 637 . 173 CaccamoA , OddoS , SugarmanMCetal . Age - andregion - dependent alterationsinAbeta - degradingenzymes : implicationsforAbeta - induceddisorders . NeurobiolAging 2005 ; 26 : 645 - 654 . 174 KoudinovAR , KoudinovaNV . Cholesterolhomeostasisfailureasa unifyingcauseofsynapticdegeneration . JNeurolSci 2005 ; 229 - 230 : 233 - 240 . 175 CafforioG , PistolesiS , D ’ AvinoCetal . Inclusionbodymyopathy associatedwithmotorneuronsyndrome : threecasereports . Clin Neuropathol 2005 ; 24 : 36 - 41 . 176 BorosS , KampsB , WunderinkLetal . Transglutaminasecatalyzes differentialcrosslinkingofsmallheatshockproteinsandamyloid - beta . FEBSLett 2004 ; 576 : 57 - 62 . 177 GossrauG , GestrichB , KochRetal . ApolipoproteinEandalpha - 1 - antichymotrypsinpolymorphismsinsporadicinclusionbodymyositis . EurNeurol 2004 ; 51 : 215 - 220 . 178 FidzianskaA , Rowinska - MarcinskaK , Hausmanowa - PetrusewiczI . CoexistenceofX - linkedrecessiveEmery - Dreifussmuscular dystrophywithinclusionbodymyositis - likemorphology . Acta Neuropathol ( Berl ) 2004 ; 107 : 197 - 203 . 179 LampeJB , GossrauG , KempeAetal . AnalysisofHLAclassIandII allelesinsporadicinclusion - bodymyositis . JNeurol 2003 ; 250 : 1313 - 1317 . 180 NirmalananthanN , HoltonJL , HannaMG . Isitreallymyositis ? A considerationofthedifferentialdiagnosis . CurrOpinRheumatol 2004 ; 16 : 684 - 691 . 181 MaurageCA , BussiereT , SergeantNetal . Tauaggregatesare abnormallyphosphorylatedininclusionbodymyositisandhaveanimmunoelectrophoreticprofiledistinctfromothertauopathies . NeuropatholApplNeurobiol 2004 ; 30 : 624 - 634 . 182 PriceP , SantosoL , MastagliaFetal . Twomajorhistocompatibility complexhaplotypesinfluencesusceptibilitytosporadicinclusionbodymyositis : criticalevaluationofanassociationwithHLA - DR3 . TissueAntigens 2004 ; 64 : 575 - 580 . 183 DalakasMC . Theuseofintravenousimmunoglobulininthe treatmentofautoimmuneneuromusculardiseases : evidence - based indicationsandsafetyprofile . PharmacolTher 2004 ; 102 : 177 - 193 . 184 DalakasMC . Intravenousimmunoglobulininautoimmune neuromusculardiseases . JAMA 2004 ; 291 : 2367 - 2375 . 185 OliveM , UnzetaM , MorenoD , FerrerI . Overexpressionof semicarbazide - sensitiveamineoxidaseinhumanmyopathies . MuscleNerve 2004 ; 29 : 261 - 266 . 186 BronnerIM , LinssenWH , vanderMeulenMFetal . Polymyositis : an ongoingdiscussionaboutadiseaseentity . ArchNeurol 2004 ; 61 : 132 - 135 . 187 TsengBP , KitazawaM , LaFerlaFM . Amyloidbeta - peptide : theinside story . CurrAlzheimerRes 2004 ; 1 : 231 - 239 . 188 AskanasV , EngelWK . Unicorns , dragons , polymyositis , andother mythicalbeasts . Neurology 2004 ; 63 : 403 - 404 , authorreply404 . 189 ChitnisT , KhourySJ . 20 . Immunologicneuromusculardisorders . J AllergyClinImmunol 2003 ; 111 : S659 - 668 . 190 AskanasV , EngelWK , McFerrinJ , VattemiG . TransthyretinVal122Ile , accumulatedAbeta , andinclusion - bodymyositisaspectsincultured muscle . Neurology 2003 ; 61 : 257 - 260 . 191 DalakasMC , HohlfeldR . Polymyositisanddermatomyositis . Lancet 2003 ; 362 : 971 - 982 . 192 DerkCT , VivinoFB , KenyonL , MandelS . Inclusionbodymyositisin connectivetissuedisorders : casereportandreviewoftheliterature . ClinRheumatol 2003 ; 22 : 324 - 328 . 193 MassawiG , HicklingP , HiltonD , PattersonC . Inclusionbodymyositis evolvinginsystemiclupuserythrematosus ? Acasereport . Rheumatology ( Oxford ) 2003 ; 42 : 1012 - 1014 . RESEARCH BMJ | ONLINE FIRST | bmj . com page 11 of 14 194 MuntzingK , LindbergC , MoslemiAR , OldforsA . Inclusionbody myositis : clonalexpansionsofmuscle - infiltratingTcellspersistover time . ScandJImmunol 2003 ; 58 : 195 - 200 . 195 ParissisD , KarkavelasG , TaskosN , MilonasI . Inclusionbody myositisinapatientwithapresumeddiagnosisofpost - polio syndrome . JNeurol 2003 ; 250 : 619 - 621 . 196 KrauseS , Schlotter - WeigelB , WalterMCetal . Anovelhomozygous missensemutationintheGNEgeneofapatientwithquadriceps - sparinghereditaryinclusionbodymyopathyassociatedwithmuscleinflammation . NeuromusculDisord 2003 ; 13 : 830 - 834 . 197 DalakasMC . High - doseintravenousimmunoglobulinin inflammatorymyopathies : experiencebasedoncontrolledclinical trials . NeurolSci 2003 ; 24 ( Suppl4 ) : S256 - 259 . 198 TateyamaM , SaitoN , FujiharaKetal . Familialinclusionbody myositis : areportontwoJapanesesisters . InternMed 2003 ; 42 : 1035 - 1038 . 199 FidzianskaA , KaminskaA . Congenitalmyopathywithabundantring fibres , rimmedvacuolesandinclusionbodymyositis - type inclusions . Neuropediatrics 2003 ; 34 : 40 - 44 . 200 RutkoveSB , ParkerRA , NardinRAetal . Apilotrandomizedtrialof oxandroloneininclusionbodymyositis . Neurology 2002 ; 58 : 1081 - 1087 . 201 KimSY , JeitnerTM , SteinertPM . Transglutaminasesindisease . NeurochemInt 2002 ; 40 : 85 - 103 . 202 YaziciY , KagenLJ . Clinicalpresentationoftheidiopathic inflammatorymyopathies . RheumDisClinNorthAm 2002 ; 28 : 823 - 832 . 203 vanderMeulenMF , HoogendijkJE , MoonsKGetal . Rimmedvacuoles andtheaddedvalueofSMI - 31stainingindiagnosingsporadic inclusionbodymyositis . NeuromusculDisord 2001 ; 11 : 447 - 451 . 204 PhillipsBA , CalaLA , ThickbroomGWetal . Patternsofmuscle involvementininclusionbodymyositis : clinicalandmagnetic resonanceimagingstudy . MuscleNerve 2001 ; 24 : 1526 - 1534 . 205 FeliceKJ , NorthWA . InclusionbodymyositisinConnecticut : observationsin35patientsduringan8 - yearperiod . Medicine ( Baltimore ) 2001 ; 80 : 320 - 327 . 206 CherinP , MenardD , MoutonPetal . Macrophagicmyofasciitis associatedwithinclusionbodymyositis : areportofthreecases . NeuromusculDisord 2001 ; 11 : 452 - 457 . 207 ArnardottirS , AnsvedT , NennesmoI , BorgK . Reportofapatientwith inclusionbodymyositisandCD8 + chroniclymphocyticleukaemia – post - mortemanalysisofmuscleandbrain . ActaNeurolScand 2001 ; 103 : 131 - 135 . 208 DalakasMC , KoffmanB , FujiiMetal . Acontrolledstudyof intravenousimmunoglobulincombinedwithprednisoneinthetreatmentofIBM . Neurology 2001 ; 56 : 323 - 327 . 209 OzdenS , GessainA , GoutO , MikolJ . Sporadicinclusionbody myositisinapatientwithhumanTcellleukemiavirustype1 - associatedmyelopathy . ClinInfectDis 2001 ; 32 : 510 - 514 . 210 KieseierBC , SchneiderC , ClementsJMetal . Expressionofspecific matrixmetalloproteinasesininflammatorymyopathies . Brain 2001 ; 124 : 341 - 351 . 211 LampeJB , WalterMC , ReichmannH . Neurodegeneration - associated proteinsandinflammationinsporadicinclusion - bodymyositis . Adv ExpMedBiol 2001 ; 487 : 219 - 228 . 212 KovachMJ , WaggonerB , LealSMetal . Clinicaldelineationand localizationtochromosome9p13 . 3 - p12ofauniquedominant disorderinfourfamilies : hereditaryinclusionbodymyopathy , Paget diseaseofbone , andfrontotemporaldementia . MolGenetMetab 2001 ; 74 : 458 - 475 . 213 Muller - FelberW , PongratzD , ReimersC . 64thENMCInternational Workshop : therapeuticapproachestodermatomyositis , polymyositis , andinclusionbodymyositis29 - 31January1999 , Naarden , TheNetherlands . NeuromusculDisord 2001 ; 11 : 88 - 92 . 214 YamadaT , MinoharaM , ImaisoYetal . High - dosevitaminCtherapy forinclusionbodymyositis . FukuokaIgakuZasshi 2001 ; 92 : 99 - 104 . 215 TsurutaY , YamadaT , YoshimuraTetal . Inclusionbodymyositis associatedwithhepatitisCvirusinfection . FukuokaIgakuZasshi 2001 ; 92 : 370 - 376 . 216 FamAG . Recentadvancesinthemanagementofadultmyositis . ExpertOpinInvestigDrugs 2001 ; 10 : 1265 - 1277 . 217 FukuchiK , LiL , HartM , LindseyJR . Accumulationofamyloid - beta proteininexocrineglandsoftransgenicmiceoverexpressinga carboxylterminalportionofamyloidproteinprecursor . IntJExp Pathol 2000 ; 81 : 231 - 239 . 218 CapsoniS , RubertiF , DiDanielE , CattaneoA . Musculardystrophyin adultandagedanti - NGFtransgenicmiceresemblesaninclusion bodymyopathy . JNeurosciRes 2000 ; 59 : 553 - 560 . 219 BedlackRS , StrittmatterWJ , MorgenlanderJC . ApolipoproteinEand neuromusculardisease : acriticalreviewoftheliterature . ArchNeurol 2000 ; 57 : 1561 - 1565 . 220 FrederiksePH , ZiglerSJ , Jr . , FarnsworthPN , CarperDA . Prionprotein expressioninmammalianlenses . CurrEyeRes 2000 ; 20 : 137 - 143 . 221 AskanasV , EngelWK , AlvarezRBetal . Inclusionbodymyositis , musclebloodvesselandcardiacamyloidosis , andtransthyretin Val122Ileallele . AnnNeurol 2000 ; 47 : 544 - 549 . 222 GayathriN , AnisyaV , VeerendraKumarMetal . Inclusionbody myositis ( IBM ) . ClinNeuropathol 2000 ; 19 : 13 - 20 . 223 AmemiyaK , GrangerRP , DalakasMC . ClonalrestrictionofT - cell receptorexpressionbyinfiltratinglymphocytesininclusionbodymyositispersistsovertime . Studiesinrepeatedmusclebiopsies . Brain 2000 ; 123 : 2030 - 2039 . 224 GrauJM , PereaM . Dermatomyositiswiththefeaturesofinclusion bodymyositisassociatedwithcarcinomaofthebladder : atrue association ? BrJDermatol 2000 ; 143 : 671 . 225 BoonAJ , Stolp - SmithKA . Inclusionbodymyositismasqueradingas polymyositis : acasestudy . ArchPhysMedRehabil 2000 ; 81 : 1123 - 1126 . 226 DiBlasiC , MoraM , PareysonDetal . Partiallamininalpha2chain deficiencyinapatientwithmyopathyresemblinginclusionbodymyositis . AnnNeurol 2000 ; 47 : 811 - 816 . 227 PhillipsBA , ZilkoPJ , MastagliaFL . Prevalenceofsporadicinclusion bodymyositisinWesternAustralia . MuscleNerve 2000 ; 23 : 970 - 972 . 228 WalterMC , LochmullerH , ToepferMetal . High - doseimmunoglobulin therapyinsporadicinclusionbodymyositis : adouble - blind , placebo - controlledstudy . JNeurol 2000 ; 247 : 22 - 28 . 229 NakayamaT , HoriuchiE , WatanabeTetal . Acaseofinclusionbody myositiswithbenignmonoclonalgammopathysuccessfullyrespondingtorepeatedimmunoabsorption . JNeurolNeurosurg Psychiatry 2000 ; 68 : 230 - 233 . 230 MirabellaM , ChristodoulouK , DiGiovanniSetal . AnItalianfamily withautosomalrecessivequadriceps - sparinginclusion - body myopathy ( ARQS - IBM ) linkedtochromosome9p1 . NeurolSci 2000 ; 21 : 99 - 102 . 231 KuoYM , KokjohnTA , WatsonMDetal . Elevatedabeta42inskeletal muscleofAlzheimerdiseasepatientssuggestsperipheralalterationsofAbetaPPmetabolism . AmJPathol 2000 ; 156 : 797 - 805 . 232 LimayeV , ScottG , KwiatekR , PileK . Inclusionbodymyositis associatedwithsystemiclupuserythematosus ( SLE ) . AustNZJMed 2000 ; 30 : 275 - 276 . 233 GuyerC . Recentdevelopmentsinanimalmodelsofhuman neurodegenerativediseases . ToxicolPathol 2000 ; 28 : 363 - 366 . 234 BarohnRJ , AmatoAA . InclusionBodyMyositis . CurrTreatOptions Neurol 2000 ; 2 : 7 - 12 . 235 TalaninNY , BushoreD , RasberryRetal . Dermatomyositiswiththe featuresofinclusionbodymyositisassociatedwithcarcinomaofthebladder . BrJDermatol 1999 ; 141 : 926 - 930 . 236 NakanoS , AkiguchiI , NakamuraSetal . Aberrantexpressionof cyclin - dependentkinase5ininclusionbodymyositis . Neurology 1999 ; 53 : 1671 - 1676 . 237 KokCC , CroagerEJ , WittCSetal . Mappingofacandidateregionfor susceptibilitytoinclusionbodymyositisinthehumanmajorhistocompatibilitycomplex . Immunogenetics 1999 ; 49 : 508 - 516 . 238 LampeJ , KitzlerH , WalterMCetal . Methioninehomozygosityatprion genecodon129maypredisposetosporadicinclusion - body myositis . Lancet 1999 ; 353 : 465 - 466 . 239 VillanovaM , CeuterickC , DottiMTetal . Detectionofbeta - A4amyloid anditsprecursorproteininthemuscleofapatientwithjuvenileneuronalceroidlipofuscinosis ( Spielmeyer - Vogt - Sjogren ) . Acta Neuropathol ( Berl ) 1999 ; 98 : 78 - 84 . 240 McCoyAL , BubbMR , PlotzPH , DavisJC . Inclusionbodymyositislong afterdermatomyositis : areportoftwocases . ClinExpRheumatol 1999 ; 17 : 235 - 239 . 241 MastagliaFL , PhillipsBA , ZilkoPJ . InflammatoryMyopathy . CurrTreat OptionsNeurol 1999 ; 1 : 263 - 272 . 242 FyhrIM , MoslemiAR , LindbergC , OldforsA . Tcellreceptorbeta - chain repertoireininclusionbodymyositis . JNeuroimmunol 1998 ; 91 : 129 - 134 . 243 LevineTD , PestronkA . Inflammatorymyopathywithcytochrome oxidasenegativemusclefibers : methotrexatetreatment . Muscle Nerve 1998 ; 21 : 1724 - 1728 . 244 LodiR , TaylorDJ , TabriziSJetal . Normalinvivoskeletalmuscle oxidativemetabolisminsporadicinclusionbodymyositisassessedby31P - magneticresonancespectroscopy . Brain 1998 ; 121 : 2119 - 2126 . 245 KoffmanBM , SivakumarK , SimonisTetal . HLAalleledistribution distinguishessporadicinclusionbodymyositisfromhereditaryinclusionbodymyopathies . JNeuroimmunol 1998 ; 84 : 139 - 142 . 246 BenderA , BehrensL , EngelAG , HohlfeldR . T - cellheterogeneityin musclelesionsofinclusionbodymyositis . JNeuroimmunol 1998 ; 84 : 86 - 91 . 247 vanderMeulenMF , HoogendijkJE , JansenGHetal . Absenceof characteristicfeaturesintwopatientswithinclusionbodymyositis . J NeurolNeurosurgPsychiatry 1998 ; 64 : 396 - 398 . 248 TomeFM , FardeauM . Hereditaryinclusionbodymyopathies . Curr OpinNeurol 1998 ; 11 : 453 - 459 . RESEARCH page 12 of 14 BMJ | ONLINE FIRST | bmj . com 249 DarinN , KyllermanM , WahlstromJetal . Autosomaldominant myopathywithcongenitaljointcontractures , ophthalmoplegia , and rimmedvacuoles . AnnNeurol 1998 ; 44 : 242 - 248 . 250 OyamaF , MurakamiN , IharaY . Chloroquinemyopathysuggeststhat tauisdegradedinlysosomes : implicationfortheformationofpaired helicalfilamentsinAlzheimer ’ sdisease . NeurosciRes 1998 ; 31 : 1 - 8 . 251 YangCC , AlvarezRB , EngelWKetal . Nitricoxide - inducedoxidative stressinautosomalrecessiveanddominantinclusion - body myopathies . Brain 1998 ; 121 : 1089 - 1097 . 252 HorvathR , FuK , JohnsTetal . Characterizationofthemitochondrial DNAabnormalitiesintheskeletalmuscleofpatientswithinclusionbodymyositis . JNeuropatholExpNeurol 1998 ; 57 : 396 - 403 . 253 AmatoAA , ShebertRT . Inclusionbodymyositisintwins . Neurology 1998 ; 51 : 598 - 600 . 254 DalakasMC . Controlledstudieswithhigh - doseintravenous immunoglobulininthetreatmentofdermatomyositis , inclusionbody myositis , andpolymyositis . Neurology 1998 ; 51 ( 6Suppl5 ) : S37 - 45 . 255 QuerfurthHW , JiangJ , GeigerJD , SelkoeDJ . Caffeinestimulates amyloidbeta - peptidereleasefrombeta - amyloidprecursorprotein - transfectedHEK293cells . JNeurochem 1997 ; 69 : 1580 - 1591 . 256 SivakumarK , Semino - MoraC , DalakasMC . Aninflammatory , familial , inclusionbodymyositiswithautoimmunefeaturesanda phenotypeidenticaltosporadicinclusionbodymyositis . Studiesin threefamilies . Brain 1997 ; 120 : 653 - 661 . 257 DalakasMC , SoniesB , DambrosiaJetal . Treatmentofinclusion - body myositiswithIVIg : adouble - blind , placebo - controlledstudy . Neurology 1997 ; 48 : 712 - 716 . 258 BrannaganTH , HaysAP , LangeDJ , TrojaborgW . Theroleof quantitativeelectromyographyininclusionbodymyositis . JNeurol NeurosurgPsychiatry 1997 ; 63 : 776 - 779 . 259 FyhrIM , MoslemiAR , MosaviAAetal . Oligoclonalexpansionof muscleinfiltratingTcellsininclusionbodymyositis . JNeuroimmunol 1997 ; 79 : 185 - 189 . 260 SpectorSA , LemmerJT , KoffmanBMetal . Safetyandefficacyof strengthtraininginpatientswithsporadicinclusionbodymyositis . MuscleNerve 1997 ; 20 : 1242 - 1248 . 261 PraysonRA , CohenML . Ubiquitinimmunostainingandinclusion bodymyositis : studyof30patientswithinclusionbodymyositis . HumPathol 1997 ; 28 : 887 - 892 . 262 MastagliaFL , PhillipsBA , ZilkoP . Treatmentofinflammatory myopathies . MuscleNerve 1997 ; 20 : 651 - 664 . 263 JensenML , WietingJM , AndaryMTetal . Inclusionbodymyositisand transitionalcellcarcinomaofthebladder : significantresolutionof symptomsaftertumorexcision . ArchPhysMedRehabil 1997 ; 78 : 327 - 329 . 264 DalakasMC , IllaI , GallardoE , JuarezC . Inclusionbodymyositisand paraproteinemia : incidenceandimmunopathologiccorrelations . AnnNeurol 1997 ; 41 : 100 - 104 . 265 AskanasV . Newdevelopmentsinhereditaryinclusionbody myopathies . AnnNeurol 1997 ; 41 : 421 - 422 . 266 AuthierFJ , MhiriC , ChazaudBetal . Interleukin - 1expressionin inflammatorymyopathies : evidenceofmarkedimmunoreactivityin sarcoidgranulomasandmusclefibresshowingischaemicandregenerativechanges . NeuropatholApplNeurobiol 1997 ; 23 : 132 - 140 . 267 SekulEA , ChowC , DalakasMC . Magneticresonanceimagingofthe forearmasadiagnosticaidinpatientswithsporadicinclusionbodymyositis . Neurology 1997 ; 48 : 863 - 866 . 268 BarohnRJ . Thetherapeuticdilemmaofinclusionbodymyositis . Neurology 1997 ; 48 : 567 - 568 . 269 RobertsonTA , DuttonNS , MartinsRNetal . Beta - amyloidprotein - containinginclusionsinskeletalmuscleofapolipoprotein - E - deficientmice . AmJPathol 1997 ; 150 : 417 - 427 . 270 LucianoCA , DalakasMC . Inclusionbodymyositis : noevidencefora neurogeniccomponent . Neurology 1997 ; 48 : 29 - 33 . 271 CuplerEJ , Leon - MonzonM , MillerJetal . Inclusionbodymyositisin HIV - 1andHTLV - 1infectedpatients . Brain 1996 ; 119 : 1887 - 1893 . 272 SivakumarK , DalakasMC . Thespectrumoffamilialinclusionbody myopathiesin13familiesandadescriptionofaquadriceps - sparing phenotypeinnon - IranianJews . Neurology 1996 ; 47 : 977 - 984 . 273 DeBleeckerJL , EngelAG , ErtlBB . Myofibrillarmyopathywith abnormalfociofdesminpositivity . II . Immunocytochemicalanalysis revealsaccumulationofmultipleotherproteins . JNeuropatholExp Neurol 1996 ; 55 : 563 - 577 . 274 LoveS , NicollJA , LoweJ , SherriffF . ApolipoproteinEallele frequenciesinsporadicinclusionbodymyositis . MuscleNerve 1996 ; 19 : 1605 - 1607 . 275 AmatoAA , GronsethGS , JacksonCEetal . Inclusionbodymyositis : clinicalandpathologicalboundaries . AnnNeurol 1996 ; 40 : 581 - 586 . 276 AskanasV , EngelWK , MirabellaMetal . ApolipoproteinEallelesin sporadicinclusion - bodymyositisandhereditaryinclusion - body myopathy . AnnNeurol 1996 ; 40 : 264 - 265 . 277 SantorelliFM , SciaccoM , TanjiKetal . MultiplemitochondrialDNA deletionsinsporadicinclusionbodymyositis : astudyof56patients . AnnNeurol 1996 ; 39 : 789 - 795 . 278 FeliceKJ , GrunnetML . Inclusionbodymyositisassociatedwitha severeunilaterallevodopa - responsiveupperextremitytremor . MuscleNerve 1996 ; 19 : 787 - 789 . 279 DalakasMC . Clinicalbenefitsandimmunopathologicalcorrelatesof intravenousimmuneglobulininthetreatmentofinflammatorymyopathies . ClinExpImmunol 1996 ; 104 ( Suppl1 ) : 55 - 60 . 280 NaumannM , ReichmannH , GoebelHHetal . Glucocorticoid - sensitive hereditaryinclusionbodymyositis . JNeurol 1996 ; 243 : 126 - 130 . 281 MirabellaM , AlvarezRB , BilakMetal . Differenceinexpressionof phosphorylatedtauepitopesbetweensporadicinclusion - body myositisandhereditaryinclusion - bodymyopathies . JNeuropathol ExpNeurol 1996 ; 55 : 774 - 786 . 282 AskanasV , EngelWK . ResponsetoLetterfromRosenblum , W . I . : Two distinctformsofhyperphosphorylatedtauinsporaticversushereditaryinclusionmyopathy . JNeuropatholExpNeurol 1996 ; 55 : 1179 - 1180 . 283 FioriMG , SalviF , PlasmatiR , TassinariCA . Musclefibersplitting , capillaryinternalization , andtarget - likefiberformationinfamilial amyloidoticpolyneuropathy . ClinNeuropathol 1996 ; 15 : 240 - 247 . 284 KagenLJ . Newdevelopmentsinthemyositissyndromes . BullRheum Dis 1996 ; 45 : 1 - 4 . 285 GarleppMJ , TabariasH , vanBockxmeerFMetal . ApolipoproteinE epsilon4ininclusionbodymyositis . AnnNeurol 1995 ; 38 : 957 - 959 . 286 NadkarniN , FreimerM , MendellJR . Amyloidosiscausinga progressivemyopathy . MuscleNerve 1995 ; 18 : 1016 - 1018 . 287 BarohnRJ , AmatoAA , SahenkZetal . Inclusionbodymyositis : explanationforpoorresponsetoimmunosuppressivetherapy . Neurology 1995 ; 45 : 1302 - 1304 . 288 MurakamiN , IharaY , NonakaI . Musclefiberdegenerationindistal myopathywithrimmedvacuoleformation . ActaNeuropathol ( Berl ) 1995 ; 89 : 29 - 34 . 289 CohenAS . Clinicalaspectsofamyloidosis , includingrelatedproteins andcentralnervoussystemamyloid . CurrOpinRheumatol 1994 ; 6 : 68 - 77 . 290 HarringtonCR , AndersonJR , ChanKK . ApolipoproteinEtypeepsilon4 allelefrequencyisnotincreasedinpatientswithsporadicinclusion - bodymyositis . NeurosciLett 1995 ; 183 : 35 - 38 . 291 DalakasMC . Updateontheuseofintravenousimmuneglobulinin thetreatmentofpatientswithinflammatorymuscledisease . JClin Immunol 1995 ; 15 ( 6Suppl ) : 70S - 75S . 292 DalakasMC , IllaI . Commonvariableimmunodeficiencyand inclusionbodymyositis : adistinctmyopathymediatedbynatural killercells . AnnNeurol 1995 ; 37 : 806 - 810 . 293 DasqueF , LarocheM , MarquePetal . Isokineticstrengthtestingfor evaluatingtheefficacyofintravenousimmuneglobulintherapyforinclusionbodymyositis . RevRhumEnglEd 1995 ; 62 : 598 - 601 . 294 TsuzukiK , FukatsuR , TakamaruYetal . Co - localizationofamyloid - associatedproteinswithamyloidbetainratsoleusmuscleinchloroquine - inducedmyopathy : apossiblemodelforamyloidbeta formationinAlzheimer ’ sdisease . BrainRes 1995 ; 699 : 260 - 265 . 295 GarleppMJ , LaingB , ZilkoPJetal . HLAassociationswithinclusion bodymyositis . ClinExpImmunol 1994 ; 98 : 40 - 45 . 296 TsuzukiK , FukatsuR , TakamaruYetal . Immunohistochemical evidenceforamyloidbetainratsoleusmuscleinchloroquine - inducedmyopathy . NeurosciLett 1994 ; 182 : 151 - 154 . 297 GambettiP , PerryG . Alzheimer ’ sdiseaseandprionproteins : a meetingmadeinmuscle . AmJPathol 1994 ; 145 : 1261 - 1264 . 298 AkaabouneM , MaJ , FestoffBWetal . Neurotrophicregulationof mousemusclebeta - amyloidproteinprecursorandalpha1 - antichymotrypsinasrevealedbyaxotomy . JNeurobiol 1994 ; 25 : 503 - 514 . 299 DeArmondSJ . Alzheimer ’ sdiseaseandCreutzfeldt - Jakobdisease : overlapofpathogenicmechanisms . CurrOpinNeurol 1993 ; 6 : 872 - 881 . 300 HopkinsonND , HuntC , PowellRJ , LoweJ . Inclusionbodymyositis : an underdiagnosedcondition ? AnnRheumDis 1993 ; 52 : 147 - 151 . 301 BeyenburgS , ZierzS , JerusalemF . Inclusionbodymyositis : clinical andhistopathologicalfeaturesof36patients . ClinInvestig 1993 ; 71 : 351 - 361 . 302 AskanasV , EngelWK , AlvarezRB . Strongimmunoreactivityofbeta - amyloidprecursorprotein , includingthebeta - amyloidprotein sequence , athumanneuromuscularjunctions . NeurosciLett 1992 ; 143 : 96 - 100 . 303 Wikipedia , thefreeencyclopedia . Networktheory . http : / / en . wikipedia . org / wiki / Network _ theory ( accessed24Jan2009 ) . 304 Wikipedia , thefreeencyclopedia . Centrality . http : / / en . wikipedia . org / wiki / Centrality ( accessed24Jan2009 ) . 305 NewmanMEJ . Ameasureofbetweennesscentralitybasedon randomwalks . SocialNetworks 2005 ; 27 : 39 - 54 . http : / / arxiv . org / PS _ cache / cond - mat / pdf / 0309 / 0309045v1 . pdf ( accessed24Jan2009 ) . 306 KleinbergJM . Authoritativesourcesinahyperlinkedenvironment . ProceedingsoftheACM - SIAMsymposiumondiscretealgorithms , 1998 : 668 - 77 . www . cs . cornell . edu / home / kleinber / auth . pdf ( accessed24Jan2009 ) . RESEARCH BMJ | ONLINE FIRST | bmj . com page 13 of 14 307 ClausetA , ShaliziCR , NewmanMEJ . Power - lawdistributionsin empiricaldata . http : / / arxiv . org / PS _ cache / arxiv / pdf / 0706 / 0706 . 1062v1 . pdf ( accessed24Jan2009 ) . 308 NewmanMEJAssortativitymixinginnetworks . PhysRevLett 2002 ; 89 : 208701 . RetrievedJanuary24 , 2009fromhttp : / / arxiv . org / PS _ cache / cond - mat / pdf / 0205 / 0205405v1 . pdf ( accessed24Jan 2009 ) . 309 Wikipedia , thefreeencyclopedia . Socialnetworks . http : / / en . wikipedia . org / wiki / Social _ network ( accessed24Jan2009 ) . 310 NationalInstitutesofHealthFreedomofInformationActOffice . www . nih . gov / icd / od / foia / index . htm 311 HylandK . Self - citationandself - reference : credibilityandpromotion inacademicpublication . JAmSocInformSciTechnol 2003 ; 54 : 251 - 9 . 312 GilbertGN . Referencingaspersuasion . SocStudSci 1977 ; 7 : 113 - 22 . www . jstor . org / stable / 284636 ( accessed28Feb 2009 ) . 313 GarfieldE . Citationindexesforscience . Science 1955 ; 122 : 108 - 11 . 314 DickersinK . ReportingandotherbiasesinstudiesofNeurontinfor migraine , psychiatric / bipolardisorders , nociceptivepain , and neuropathicpain . http : / / dida . library . ucsf . edu / pdf / oxx18r10 ( accessed28Feb2009 ) . 315 HengstmanGJD , vanEngelenBGM . Polymyositis , invasionofnon - necroticmusclefibres , andtheartofrepetition . BMJ 2004 ; 329 : 1464 - 7 . 316 BikhchandaniS , HirshleiferD , WelchI . Atheoryoffads , fashion , custom , andculturalchangeasinformationalcascades . JPolitical Econ 1992 ; 100 : 992 - 1026 . 317 BanerjeeAH . Asimplemodelofherdbehavior . QuartJEcon 1992 ; 107 : 797 - 817 . 318 TatsioniA , BonitsisNG , IoannidisJPA . Persistenceofcontradicted claimsintheliterature . JAMA 2007 ; 298 : 2517 - 26 . 319 Wikipedia , thefreeencyclopedia . Publicationbias . http : / / en . wikipedia . org / wiki / Publication _ bias ( accessed24Jan2009 ) . 320 HowtoWriteaResearchGrant . GuidelinesfromtheNationalInstitute ofNeurologicalDisordersandStroke . www . ninds . nih . gov / funding / write _ grant _ doc . htm ( accessed24Jan2009 ) . 321 Wikipedia , thefreeencyclopedia . Confirmationbias . http : / / en . wikipedia . org / wiki / Confirmation _ bias ( accessed24Jan2009 ) . Accepted : 17 March 2009 RESEARCH page 14 of 14 BMJ | ONLINE FIRST | bmj . com